The Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, will today start investigating genetic risk of acute pancreatitis from GLP-1 medicines, such as Ozempic and Mounjaro.
Read more: ow.ly/wWHB50WgMSR
@mhragovuk.bsky.social
Find the contact, social media, service desk, and other important information for Genomics England.
